UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report

BMC neurology, 2017-05, Vol.17 (1), p.102-102, Article 102

2017

Volltextzugriff (PDF)

MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism

American journal of neuroradiology : AJNR, 2018-06, Vol.39 (6), p.1047-1051

2018

Volltextzugriff (PDF)

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

Annals of clinical biochemistry, 2009-05, Vol.46 (Pt 3), p.235

2009

Volltextzugriff (PDF)

A Normative Study of the Trail Making Test A and B in Greek Adults

Clinical neuropsychologist, 2008-09, Vol.22 (5), p.842-850

2008

Volltextzugriff (PDF)

Circulating interleukin-10 and interleukin-12 in Parkinson's disease

Acta neurologica Scandinavica, 2009-05, Vol.119 (5), p.332-337

2009

Volltextzugriff (PDF)

The Stroop Effect in Greek Healthy Population: Normative Data for the Stroop Neuropsychological Screening Test

Archives of clinical neuropsychology, 2009-02, Vol.24 (1), p.81-88

2009

Volltextzugriff (PDF)

Circulating interleukin-15 and RANTES chemokine in Parkinson's disease

Acta neurologica Scandinavica, 2007-12, Vol.116 (6), p.374-379

2007

Volltextzugriff (PDF)

CSF biomarker profile and diagnostic value in vascular dementia

European journal of neurology, 2009-02, Vol.16 (2), p.205-211

2009

Volltextzugriff (PDF)

CSF tau protein and β-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population

European journal of neurology, 2003-03, Vol.10 (2), p.119-128

2003

Volltextzugriff (PDF)

Highly increased CSF tau protein and decreased β-amyloid (1–42) in sporadic CJD: a discrimination from Alzheimer's disease?

Journal of neurology, neurosurgery and psychiatry, 2001-09, Vol.71 (3), p.401-403

2001

Volltextzugriff (PDF)

A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia

Dementia and geriatric cognitive disorders, 2007-01, Vol.24 (6), p.434

2007

Volltextzugriff (PDF)

Incidence and Clinical Presentation of Neurosyphilis: A Retrospective Study of 81 Cases

International journal of neuroscience, 2008-09, Vol.118 (9), p.1251-1257

2008

Volltextzugriff (PDF)

IL-15 Is Elevated in Cerebrospinal Fluid of Patients With Alzheimer’s Disease and Frontotemporal Dementia

Journal of geriatric psychiatry and neurology, 2006-06, Vol.19 (2), p.114-117

2006

Volltextzugriff (PDF)

The cognitive effects of cholinesterase inhibitor treatment in every-day practice

Current medical research and opinion, 2005-06, Vol.21 (6), p.871-875

2005

Volltextzugriff (PDF)

Serum Levels of Soluble Intercellular Adhesion Molecule-1 and Soluble Endothelial Leukocyte Adhesion Molecule-1 in Alzheimer’s Disease

Journal of geriatric psychiatry and neurology, 2004-12, Vol.17 (4), p.225-231

2004

Volltextzugriff (PDF)

Cerebrospinal fluid tau, phospho-tau181 and β-amyloid1−42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease

European journal of neurology, 2007-02, Vol.14 (2), p.168-173

2007

Volltextzugriff (PDF)

Changes in blood neurotransmitter and steroid levels during evoked vertigo

Otology & neurotology, 2005-05, Vol.26 (3), p.476

2005

Volltextzugriff (PDF)

Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?

Journal of Alzheimer's disease, 2015-01, Vol.47 (4), p.1069

2015

Volltextzugriff (PDF)

Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease

Acta neurologica Scandinavica, 1997-08, Vol.96 (2), p.88-90

1997

Volltextzugriff (PDF)

Cortical atrophy detected by computed tomography in gasoline station attendants

The Science of the total environment, 1999-10, Vol.239 (1), p.143-149

1999

Volltextzugriff (PDF)

Novel mutations and repeated findings of mutations in familial Alzheimer disease

Neurogenetics, 2005-05, Vol.6 (2), p.85-89

2005

Volltextzugriff (PDF)

The diagnostic value of tau protein, β-amyloid (1-42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages

International journal of geriatric psychiatry, 2005-08, Vol.20 (8), p.722-729

2005

Volltextzugriff (PDF)

Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment

Clinical neurology and neurosurgery, 2008-03, Vol.110 (3), p.222-226

2008

Volltextzugriff (PDF)

Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders

Acta neurologica Scandinavica, 1989-05, Vol.79 (5), p.373-378

1989

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(53)
Berichte
(1)

Sprache

Englisch
(54)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(46)
Science & Technology
(46)
Life Sciences & Biomedicine
(45)
Male
(40)
Female
(36)
Middle Aged
(36)
Neurosciences & Neurology
(32)
Biological And Medical Sciences
(27)
Clinical Neurology
(27)
Medical Sciences
(26)
Aged
(24)
Alzheimer's Disease
(22)
Neurology
(21)
Adult
(20)
Cerebrospinal Fluid
(15)
Neurosciences
(15)
Alzheimer Disease - Cerebrospinal Fluid
(14)
Tau Proteins - Cerebrospinal Fluid
(11)
Alzheimer Disease - Diagnosis
(10)
Amyloid Beta-Peptides - Cerebrospinal Fluid
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report

MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

A Normative Study of the Trail Making Test A and B in Greek Adults

Circulating interleukin-10 and interleukin-12 in Parkinson's disease

The Stroop Effect in Greek Healthy Population: Normative Data for the Stroop Neuropsychological Screening Test

Circulating interleukin-15 and RANTES chemokine in Parkinson's disease

CSF biomarker profile and diagnostic value in vascular dementia

CSF tau protein and β-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population

Highly increased CSF tau protein and decreased β-amyloid (1–42) in sporadic CJD: a discrimination from Alzheimer's disease?

A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia

Incidence and Clinical Presentation of Neurosyphilis: A Retrospective Study of 81 Cases

IL-15 Is Elevated in Cerebrospinal Fluid of Patients With Alzheimer’s Disease and Frontotemporal Dementia

The cognitive effects of cholinesterase inhibitor treatment in every-day practice

Serum Levels of Soluble Intercellular Adhesion Molecule-1 and Soluble Endothelial Leukocyte Adhesion Molecule-1 in Alzheimer’s Disease

Cerebrospinal fluid tau, phospho-tau181 and β-amyloid1−42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease

Changes in blood neurotransmitter and steroid levels during evoked vertigo

Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease

Cortical atrophy detected by computed tomography in gasoline station attendants

Novel mutations and repeated findings of mutations in familial Alzheimer disease

The diagnostic value of tau protein, β-amyloid (1-42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages

Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment

Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders

Suchergebnisse filtern